Abstract
This paper tries to quantify the impact of government policy intervention on the death due to COVID-19 in India. I use the Oxford COVID-19 Government Response Tracker (OxCGRT), a longitudinal database of daily government response from Jan 28th, 2020, when the first COVID case was diagnosed in India till December 31st, 2022. Here government responses are captured in form of, stringency measures, containment measures, economic support measures, and the overall government support, providing a holistic assessment of the government’s efforts in mitigating the virus’s incidence. I quantify both the average relation and causality at the to understand the impacts of NPIs with COVID-19 incidence in terms of deaths and infections due to COVID-19. Short-term analysis reveals a significant relationship between various non-pharmaceutical interventions (NPIs) and the logarithmic change in COVID-19 deaths. Higher infection rates are strongly associated with increased deaths, with positive coefficients. Stringent measures, containment actions, and economic support show negative coefficients, indicating that these interventions effectively reduce deaths in the short term. The overall government support, which aggregates all three NPIs, also demonstrates a significant negative effect on deaths, highlighting the importance of stringent and immediate measures in controlling the death toll early in the pandemic. In the long term, the analysis continues to emphasize the importance of infection rates and NPIs. Long-term coefficients for infection rates and various NPIs are consistently significant and negative, indicating that sustained interventions significantly reduce mortality over time. Specific measures like stringency, containment, and economic support show substantial negative impacts underscoring the long-term benefits of maintaining rigorous public health measures. Further, causality analysis confirms that relationship among government interventions and COVID-19 incidences were mostly bidirectional, meaning more deaths (or infections) leads to stricter interventions that in turn further reduce deaths.
JEL C23, C54, I18, I38
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study uses data openly available at OXCGRT database hosted by Oxford University.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Methodology and findings are revised.
Data Availability
All data produced are available online at OXCGRT Database
https://www.bsg.ox.ac.uk/research/covid-19-government-response-tracker
